Invention Grant
- Patent Title: Purification of factor VIII subspecies
-
Application No.: US16015452Application Date: 2018-06-22
-
Publication No.: US11299533B2Publication Date: 2022-04-12
- Inventor: Meinhard Hasslacher , Martin Feichtinger , Philipp M. Bärnthaler , Christa Mayer , Birgit Reipert , Mantas Malisauskas , Julia Anzengruber
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Troutman Pepper Hamilton Sanders LLP
- Priority: EP17177749 20170623
- Main IPC: C07K14/755
- IPC: C07K14/755 ; B01D15/32 ; B01D15/36 ; B01D15/34 ; C07K1/16 ; C07K1/18 ; C07K1/36 ; A61K38/00
Abstract:
The present invention relates to a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also relates to a composition comprising a purified FVIII subspecies.
Public/Granted literature
- US20190062403A1 PURIFICATION OF FACTOR VIII SUBSPECIES Public/Granted day:2019-02-28
Information query
